Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets

被引：36

作者：

Ren, Kun ^{[1
,2
]}

Jiang, Ting ^{[1
]}

Zheng, Xi-Long ^{[3
]}

Zhao, Guo-Jun ^{[1
]}

机构：

[1] Guilin Med Univ, Dept Histol & Embryol, Guilin 541004, Guangxi, Peoples R China

[2] Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang 421001, Peoples R China

[3] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Hlth Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada

来源：

ATHEROSCLEROSIS | 2017年 / 262卷

基金：

中国博士后科学基金;

关键词：

Furin; Atherosclerosis; Lipid metabolism; Inflammation; SMOOTH-MUSCLE-CELLS; EPITHELIAL SODIUM-CHANNEL; MATRIX-METALLOPROTEINASE; BLOOD-PRESSURE; TGF-BETA; ENDOTHELIAL LIPASE; FURIN CLEAVAGE; IGF-I; RECEPTOR; GROWTH;

D O I：

10.1016/j.atherosclerosis.2017.04.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Furin, a member of the mammalian proprotein convertases family, can promote the proteolytic maturation of proproteins. It is known that furin is predominantly present in certain cell types of human atherosclerotic lesions and neointima in animal models, including vascular smooth muscle cells, endothelial cells and mononuclear inflammatory cells. Evidence suggests that furin participates in the initiation and progression of atherosclerosis through regulation of lipid and cholesterol metabolism, inflammatory response, blood pressure and the formation of atherosclerotic lesions. This review provides a panorama of the roles of furin in atherosclerosis and the insights into the prevention and treatment of atherosclerosis and cardiovascular disease. (C) 2017 Elsevier B.V. All rights reserved.

引用

页码：163 / 170

页数：8

共 102 条

[1]

Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571

[2] Pro-domain in precursor nerve growth factor mediates cell death [J].

Armugam, Arunmozhiarasi ;

Koh, Dawn C. I. ;

Ching, Chai Siaw ;

Chandrasekaran, Karthikeyan ;

Kaur, Prameet ;

Jeyaseelan, Kandiah .

NEUROCHEMISTRY INTERNATIONAL, 2012, 60 (08) :852-863

[3] Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction [J].

Asada, Mariko ;

Morioka, Tomoaki ;

Yamazaki, Yuko ;

Kakutani, Yoshinori ;

Kawarabayashi, Reina ;

Motoyama, Koka ;

Mori, Katsuhito ;

Fukumoto, Shinya ;

Shioi, Atsushi ;

Shoji, Tetsuo ;

Emoto, Masanori ;

Inaba, Andmasaaki .

JOURNAL OF DIABETES RESEARCH, 2016, 2016

[4] Transforming growth factor β signaling, vascular remodeling, and hypertension [J].

August, P ;

Suthanthiran, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (25) :2721-2723

[5] Blood pressure homeostasis is maintained by a P311-TGF-β axis [J].

Badri, Kameswara Rao ;

Yue, Ming ;

Carretero, Oscar A. ;

Aramgam, Latha ;

Cao, Jun ;

Sharkady, Stephen ;

Kim, Gene H. ;

Taylor, Gregory A. ;

Byron, Kenneth L. ;

Schuger, Lucia .

JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (10) :4502-4512

[6] The IGF-I receptor in cancer research [J].

Baserga, R .

EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :1-6

[7] Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases [J].

Becker, Gero L. ;

Lu, Yinghui ;

Hardes, Kornelia ;

Strehlow, Boris ;

Levesque, Christine ;

Lindberg, Iris ;

Sandvig, Kirsten ;

Bakowsky, Udo ;

Day, Robert ;

Garten, Wolfgang ;

Steinmetzer, Torsten .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (26) :21992-22003

[8] The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A-Functional consequences of natural mutations and post-translational modifications [J].

Benjannet, Suzanne ;

Rhainds, David ;

Hamelin, Josee ;

Nassoury, Nasha ;

Seidah, Nabil G. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (41) :30561-30572

[9] Selective αvβ3-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit [J].

Bishop, GG ;

McPherson, JA ;

Sanders, JM ;

Hesselbacher, SE ;

Feldman, MJ ;

McNamara, CA ;

Gimple, LW ;

Powers, ER ;

Mousa, SA ;

Sarembock, IJ .

CIRCULATION, 2001, 103 (14) :1906-1911

[10] Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions -: Colocalization implicates TGF-β in fibrofatty lesion development [J].

Bobik, A ;

Agrotis, A ;

Kanellakis, P ;

Dilley, R ;

Krushinsky, A ;

Smirnov, V ;

Tararak, E ;

Condron, M ;

Kostolias, G .

CIRCULATION, 1999, 99 (22) :2883-2891

← 1 2 3 4 5 6 7 8 9 10 →